Kaiku Health, together with Oulu University Hospital and Vaasa Central Hospital, presents research at the virtual ESMO Congress 2021. The research investigates how ePRO follow-up affects patient care of colorectal cancer patients receiving oxaliplatin-based adjuvant chemotherapy.
According to the results, ePRO follow-up was found to be good with 98% of the patients suggesting that the use of the platform was easy and 86% felt that it improved their cancer care. The ePRO follow-up detects evolving neuropathy earlier enhancing symptom management without compromising chemotherapy dose intensity, thus improving the quality of cancer care.
“ePRO Follow-Up of Colorectal Cancer Patients Receiving Oxaliplatin-Based Adjuvant Chemotherapy is Feasible and Enhances the Quality of Patient Care”
First author: Sanna Iivanainen (Oulu University Hospital)
Poster #: 1695P
The poster will be presented at the ESMO Virtual Congress 2021 from September 16th to September 21st on the Congress platform. The congress is one of the leading global events in the field of oncology, organised by the European Society for Medical Oncology. Annually significant and some of the most promising scientific research in the field of oncology is presented at the congress.
